|
Index of reports
> All cases (88)
Below is the selection of adverse event reports related to Glyburide that includes all cases.
Reports 1 - 25 of 88 Next >>
Adverse event in receiving Glyburide
Reported by a individual with unspecified qualification from United States on 2007-10-31
Patient:
Adverse reactions / side effects: Confusional State, Abdominal Pain, Agitation, Blood Creatine Phosphokinase Increased, Hypoglycaemia, Pain, Tachycardia, Coma, Pyrexia, Intentional Drug Misuse, Acidosis, Somnolence, Hyperhidrosis, Intentional Self-Injury, Overdose, Medication Error, Blood Electrolytes Abnormal, Dizziness, Coordination Abnormal, Vomiting, Nausea, Hyperglycaemia, Convulsion, Dysarthria, Syncope, Renal Failure, Diarrhoea, Suicide Attempt, Bradycardia, Hypertension
Adverse event resulted in: life threatening event, disablity
Suspect drug(s):
Glyburide
Adverse event in 59 year old male receiving Glyburide
Reported by a pharmacist from United States on 2007-10-24
Patient: 59 year old male
Adverse reactions / side effects: Hypoglycaemia, Muscular Weakness, Asthenia, Fall
Adverse event resulted in: hospitalization
Suspect drug(s):
Glyburide
Dosage: 10mg bid po
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2007-07-02
End date: 2007-10-10
Insulin
Dosage: 80units once sq
Start date: 2007-01-04
Adverse event in 69 year old female receiving Glyburide
Reported by a physician from United States on 2007-10-22
Patient: 69 year old female
Adverse reactions / side effects: Liver Injury, Upper Respiratory Tract Infection, Hepatitis B
Suspect drug(s):
Doxycycline
Start date: 2006-12-08
End date: 2006-12-14
Glyburide
Start date: 2006-09-12
End date: 2006-12-14
Other drugs received by patient: Methotrexate; Rosuvastatin; Felodipine; Potassium Chloride; Nabumetone; Folic Acid; Levaquin; Acetaminophen
Adverse event in 58 year old female receiving Glyburide
Reported by a physician from United States on 2007-10-18
Patient: 58 year old female, weighing 144.2 kg (317.3 pounds)
Adverse reactions / side effects: Weight Decreased, Drug Ineffective, Hypoglycaemia, Hepatic Failure, Headache, Hyperhidrosis, Cardiac Disorder, Herpes Zoster, Weight Increased, Blood Uric Acid Decreased, Kidney Infection, Transient Ischaemic Attack, Diabetes Mellitus Inadequate Control, Cardiac Failure Congestive, Renal Haemorrhage, Cellulitis, Nausea, Rash, Tremor, Renal Failure, Arthralgia, Diabetic Neuropathy, Swelling, Asthenia, Angiopathy, Influenza Like Illness
Adverse event resulted in: hospitalization
Suspect drug(s):
Actos
Dosage: see image
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
End date: 2006-01-01
Actos
Dosage: see image
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2001-01-01
Actos
Dosage: see image
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2002-01-01
Actos
Dosage: see image
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2006-01-01
Actos
Glyburide
Dosage: 5 mg, 3 in 1 d, per oral
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2001-01-01
Glipizide
Dosage: 5 mg, 3 in 1 d, per oral
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2004-01-01
Lyrica
Dosage: per oral
Administration route: Oral
Indication: Diabetic Neuropathy
Start date: 2004-01-01
End date: 2004-01-01
Byetta
Dosage: 5 mcg, 2 in 1 d, subcutaneous
Indication: Type 2 Diabetes Mellitus
Start date: 2007-07-01
Byetta
Dosage: 5 mcg, 2 in 1 d, subcutaneous
Indication: Weight Decreased
Start date: 2007-07-01
Levaquin
Dosage: 750 mg, 1 in 1 d, intravenous
Indication: Kidney Infection
Start date: 2007-01-01
End date: 2007-01-01
Other drugs received by patient: Ibuprofen; Atacand (Candesartan Cilexetil) (16 Milligram); Lasix (Furosemide) (20 Milligram); Demadex; Nitrostat
Adverse event in 83 year old male receiving Glyburide
Reported by a physician from United States on 2007-10-17
Patient: 83 year old male
Adverse reactions / side effects: Hypoglycaemia
Adverse event resulted in: hospitalization
Suspect drug(s):
Januvia
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2007-07-01
End date: 2007-07-29
Glyburide
End date: 2007-07-29
Other drugs received by patient: Metformin
Adverse event in 57 year old male receiving Glyburide
Reported by a pharmacist from Japan on 2007-10-15
Patient: 57 year old male
Adverse reactions / side effects: Rhabdomyolysis, Pyrexia
Suspect drug(s):
Glyburide
Administration route: Oral
Indication: Diabetes Mellitus
Glyburide
Administration route: Oral
Other drugs received by patient: Melbin / 00082702 /
Adverse event in 68 year old male receiving Glyburide
Reported by a pharmacist from United States on 2007-10-12
Patient: 68 year old male
Adverse reactions / side effects: Unresponsive TO Stimuli, Hypoglycaemia
Adverse event resulted in: hospitalization
Suspect drug(s):
Glyburide
Adverse event in 73 year old female receiving Glyburide
Reported by a health professional (non-physician/pharmacist) from Germany on 2007-10-12
Patient: 73 year old female
Adverse reactions / side effects: Renal Failure, Diabetes Mellitus, Drug Ineffective, Cytolytic Hepatitis, Dehydration
Adverse event resulted in: hospitalization
Suspect drug(s):
Glucophage
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
End date: 2007-09-13
Crestor
Administration route: Oral
Indication: Hypercholesterolaemia
Start date: 2006-11-01
End date: 2007-09-14
Glyburide
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
End date: 2007-09-13
Acarbose
Dosage: 100 mg tablet
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
End date: 2007-09-13
Amlor
Dosage: 5 mg tablet
Administration route: Oral
Start date: 2004-01-01
End date: 2007-09-13
Other drugs received by patient: Sectral; Lexomil; Imovane; Kardegic
Adverse event in receiving Glyburide
Reported by a individual with unspecified qualification from Italy on 2007-10-11
Patient:
Adverse reactions / side effects: Lung Neoplasm Malignant
Suspect drug(s):
Glyburide
Indication: Type 2 Diabetes Mellitus
Metformin HCL
Indication: Type 2 Diabetes Mellitus
Gliclazide
Indication: Type 2 Diabetes Mellitus
Glipizide
Indication: Type 2 Diabetes Mellitus
Glimepiride
Indication: Type 2 Diabetes Mellitus
Gliquidone
Indication: Type 2 Diabetes Mellitus
Glycyclamide
Indication: Type 2 Diabetes Mellitus
Chlorpropamide
Indication: Type 2 Diabetes Mellitus
Glibomet
Indication: Type 2 Diabetes Mellitus
Adverse event in receiving Glyburide
Reported by a individual with unspecified qualification from Italy on 2007-10-11
Patient:
Adverse reactions / side effects: Acute Myocardial Infarction
Suspect drug(s):
Glyburide
Indication: Type 2 Diabetes Mellitus
Metformin HCL
Indication: Type 2 Diabetes Mellitus
Gliclazide
Indication: Type 2 Diabetes Mellitus
Glipizide
Indication: Type 2 Diabetes Mellitus
Glimepiride
Indication: Type 2 Diabetes Mellitus
Gliquidone
Indication: Type 2 Diabetes Mellitus
Glycyclamide
Indication: Type 2 Diabetes Mellitus
Chlorpropamide
Indication: Type 2 Diabetes Mellitus
Actos
Adverse event in male receiving Glyburide
Reported by a physician from United States on 2007-10-09
Patient: male, weighing 106.1 kg (233.5 pounds)
Adverse reactions / side effects: Pruritus, Therapeutic Response Unexpected With Drug Substitution
Suspect drug(s):
Glyburide
Adverse event in receiving Glyburide
Reported by a pharmacist from Japan on 2007-10-05
Patient:
Adverse reactions / side effects: Rhabdomyolysis, Pyrexia
Suspect drug(s):
Glyburide
Other drugs received by patient: Unknown Drug
Adverse event in 78 year old female receiving Glyburide
Reported by a consumer/non-health professional from France on 2007-10-05
Patient: 78 year old female
Adverse reactions / side effects: Thrombocytopenia, Epistaxis, Haematoma
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Avandia
Dosage: 1tab per day
Administration route: Oral
Start date: 2003-01-01
End date: 2007-06-30
Glyburide
Dosage: 2500mcg per day
Administration route: Oral
Start date: 2003-01-01
End date: 2007-06-30
Adverse event in female receiving Glyburide
Reported by a health professional (non-physician/pharmacist) from France on 2007-10-04
Patient: female
Adverse reactions / side effects: Cytolytic Hepatitis
Adverse event resulted in: hospitalization
Suspect drug(s):
Crestor
Administration route: Oral
Indication: Hypercholesterolaemia
Start date: 2006-11-01
End date: 2007-09-14
Glyburide
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
End date: 2007-09-13
Acarbose
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
End date: 2007-09-13
Amlor
Administration route: Oral
Start date: 2004-01-01
End date: 2007-09-12
Glucophage
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
End date: 2007-09-13
Other drugs received by patient: Sectral; Lexomil; Imovane; Kardegic
Adverse event in male receiving Glyburide
Reported by a consumer/non-health professional from United States on 2007-07-31
Patient: male
Adverse reactions / side effects: Dyspnoea, Diabetes Mellitus, Palpitations, Heart Rate Increased, Stomach Discomfort, Dizziness, Tooth Infection, Muscle Spasms
Suspect drug(s):
Glyburide
Indication: Diabetes Mellitus
Start date: 2007-01-01
End date: 2007-01-01
Metformin HCL
Indication: Diabetes Mellitus
Other drugs received by patient: Actos; Clopidogrel; Simvastatin; Vitamin CAP; Glucovance
Adverse event in 78 year old female receiving Glyburide
Reported by a pharmacist from Japan on 2007-07-30
Patient: 78 year old female, weighing 42.0 kg (92.4 pounds)
Adverse reactions / side effects: Drug Eruption, Oral Intake Reduced, Stomatitis, Rash Generalised, Mouth Ulceration, Rash, Oral Neoplasm, Eating Disorder, Oedema Mouth, Blood Glucose Increased, Stevens-Johnson Syndrome
Adverse event resulted in: hospitalization
Suspect drug(s):
Allopurinol
Dosage: 100mg per day
Administration route: Oral
Indication: Hyperuricaemia
Start date: 2007-05-11
End date: 2007-06-01
Towamin
Dosage: 50mg per day
Administration route: Oral
Indication: Hypertension
End date: 2007-06-04
Diovan
Dosage: 80mg twice per day
Administration route: Oral
Indication: Hypertension
End date: 2007-06-04
Coniel
Dosage: 4mg twice per day
Administration route: Oral
Indication: Hypertension
End date: 2007-06-04
Natrix
Dosage: 2mg per day
Administration route: Oral
Indication: Hypertension
End date: 2007-06-04
Furosemide
Dosage: 40mg per day
Administration route: Oral
Indication: Hypertension
End date: 2007-06-04
Glyburide
Dosage: 1.25mg per day
Administration route: Oral
Indication: Diabetes Mellitus
End date: 2007-06-19
Tagamet
Dosage: 200mg twice per day
Administration route: Oral
Indication: Gastritis
End date: 2007-06-04
Mecobalamin
Dosage: 500mcg twice per day
Administration route: Oral
Indication: Neuropathy Peripheral
End date: 2007-06-04
Other drugs received by patient: Japanese Medication; Halcion
Adverse event in 53 year old male receiving Glyburide
Reported by a pharmacist from United States on 2007-07-30
Patient: 53 year old male
Adverse reactions / side effects: Nausea, Hypoglycaemia, Inadequate Diet
Adverse event resulted in: hospitalization
Suspect drug(s):
PEG-Intron
Dosage: 1500mcg qweek sq
Indication: Hepatitis C
Start date: 2007-07-11
Glyburide
Dosage: 5mg bid po
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2007-02-08
Adverse event in female receiving Glyburide
Reported by a consumer/non-health professional from United States on 2007-07-25
Patient: female
Adverse reactions / side effects: Death
Adverse event resulted in: death
Suspect drug(s):
Avandia
Administration route: Oral
Glyburide
Insulin
Unspecified Medication
Adverse event in 64 year old female receiving Glyburide
Reported by a consumer/non-health professional from United States on 2007-07-23
Patient: 64 year old female
Adverse reactions / side effects: Weight Increased, Blood Glucose Decreased, Swelling, Skin Tightness
Suspect drug(s):
Avandia
Administration route: Oral
End date: 2006-01-01
Glyburide
Dosage: 4mg three times per day
Administration route: Oral
End date: 2006-12-27
Byetta
Dosage: 5mcg twice per day
Start date: 2006-11-01
Adverse event in 91 year old male receiving Glyburide
Reported by a pharmacist from United States on 2007-07-19
Patient: 91 year old male
Adverse reactions / side effects: Hypoglycaemia
Adverse event resulted in: hospitalization
Suspect drug(s):
Glyburide
Adverse event in female receiving Glyburide
Reported by a consumer/non-health professional from United States on 2007-07-18
Patient: female, weighing 98.0 kg (215.6 pounds)
Adverse reactions / side effects: Glycosylated Haemoglobin Increased, Blood Glucose Increased
Suspect drug(s):
Chantix
Indication: EX-Smoker
Start date: 2007-03-15
End date: 2007-04-01
Glyburide
Indication: Type 2 Diabetes Mellitus
Other drugs received by patient: Synthroid; Lisinopril
Adverse event in 77 year old male receiving Glyburide
Reported by a pharmacist from United States on 2007-07-13
Patient: 77 year old male
Adverse reactions / side effects: Hypoglycaemia
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Glyburide
Dosage: 10mg bid po
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 1998-09-14
End date: 2007-06-02
Rosiglitazone
Dosage: 8mg every day po
Administration route: Oral
Start date: 2000-10-16
End date: 2007-06-02
Adverse event in 55 year old male receiving Glyburide
Reported by a pharmacist from United States on 2007-07-12
Patient: 55 year old male
Adverse reactions / side effects: Hypoglycaemia, Mental Status Changes
Adverse event resulted in: hospitalization
Suspect drug(s):
Glyburide
Adverse event in receiving Glyburide
Reported by a individual with unspecified qualification from United States on 2007-07-03
Patient:
Adverse reactions / side effects: Dyspnoea, Swelling
Suspect drug(s):
Glyburide
Adverse event in 76 year old female receiving Glyburide
Reported by a physician from Germany on 2007-07-02
Patient: 76 year old female, weighing 65.0 kg (143.0 pounds)
Adverse reactions / side effects: Hyperkalaemia, Hypoglycaemia, Unevaluable Event, Depression, Hypertension
Adverse event resulted in: hospitalization
Suspect drug(s):
Temodal
Indication: Glioblastoma
Glyburide
Indication: Diabetes Mellitus
End date: 2007-05-29
Glucophage
Indication: Drug USE FOR Unknown Indication
End date: 2007-05-29
Other drugs received by patient: Cotrim DS
Page 1 Next >>
|
